The Pitts (GI Translational Research) Lab is focused on developing new novel therapies for colorectal and pancreatic cancers and in finding rational combination partners for molecularly-targeted anticancer and immunotherapy agents.
The Messersmith lab implements a personalized approach in developing new anticancer drugs for GI cancers by using novel colorectal and pancreatic explant models.